R&D channel feed

Nu­va­tion Bio to head to FDA with pooled ROS1-pos­i­tive lung can­cer da­ta

8 months ago

Up­dat­ed: GSK, iTeos re­ju­ve­nate strug­gling TIG­IT space with pos­i­tive Phase 2 Jem­per­li com­bo da­ta in lung can­cer

8 months ago
Pharma

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

8 months ago
People

Atea's poly­merase in­hibitor fails in late-stage Covid-19 treat­ment tri­al

8 months ago
Coronavirus

Onc­ter­nal stops can­cer tri­als and be­gins search for fu­ture busi­ness op­tions

8 months ago

Neu­ro­crine culls Phase 2 neu­ropsych med af­ter fail­ing to val­i­date ear­li­er da­ta

8 months ago

Seres' mi­cro­bio­me ther­a­py re­duces in­fec­tions in stem cell trans­plant pa­tients, but next steps are un­clear

8 months ago

Ful­crum's Phase 3 for old GSK drug fails, stock sinks

8 months ago

Gilead says twice-year­ly HIV pre­ven­tion shot suc­ceeds in sec­ond piv­otal tri­al

8 months ago
Pharma

Au­ra's in­frared light-ac­ti­vat­ed drug stops tu­mor growth and pre­serves vi­sion in eight eye can­cer pa­tients

8 months ago

Mod­er­na plans $1.1B in R&D and pro­gram cuts, de­lays break-even point to 2028

8 months ago

Sanofi buys in­to ra­dio­phar­ma­ceu­ti­cal field with $110M up­front, go­ing af­ter space held by No­var­tis

8 months ago
Deals
Pharma

No­vo Nordisk's long­stand­ing GLP-1 re­duced BMI by 7% in chil­dren in Phase 3 tri­al

8 months ago

Roche says its Car­mot-ac­quired obe­si­ty pill is ef­fec­tive in ear­ly study

8 months ago

In­novent Bi­o­log­ics high­lights sub­group of lung can­cer pa­tients in ear­ly-stage study of bis­pe­cif­ic

8 months ago

Sanofi, Re­gen­eron prep an­oth­er FDA sub­mis­sion for Dupix­ent, this time for a rare skin con­di­tion

8 months ago

Novo's oral amy­cretin could lead to more weight loss be­yond 12 weeks, ac­cord­ing to ear­ly-stage tri­al

8 months ago

GSK dis­con­tin­ues her­pes ther­a­peu­tic vac­cine af­ter Phase 2 dis­ap­point­ment

8 months ago

Sanofi, Re­gen­eron to re­file Dupix­ent for skin con­di­tion af­ter new study win

8 months ago
FDA+

Bridge­Bio ends de­vel­op­ment of gene ther­a­py for adren­al gland dis­or­der

8 months ago
Cell/Gene Tx

Adicet fol­lows oth­er cell ther­a­py biotechs in au­toim­mune piv­ot

8 months ago
Pharma

Lil­ly's week­ly in­sulin hits pri­ma­ry end­points in two more late-stage di­a­betes stud­ies

8 months ago
Pharma

Roche's dual GLP-1/GIP re­sults show promis­ing weight loss, but al­so high rates of vom­it­ing

8 months ago
Pharma

Ex­clu­sive: A male con­tra­cep­tive may pre­vent 99% of preg­nan­cies. Now it’s up to a small biotech to fin­ish test­ing it

8 months ago
Startups
First page Previous page 27282930313233 Next page Last page
A service from the Financial Times